Skip to main content

Advertisement

SpringerLink
Log in

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

To develop a population pharmacokinetic model of vinorelbine administered by short intravenous infusion in metastatic breast cancer patients.

Methods

Vinorelbine was administered as infusions of 5–10 min at 15, 20 or 25 mg/m2 to 30 patients. Blood samples were collected over 18 h. Plasma concentrations of vinorelbine were determined by HPLC. Population pharmacokinetic analysis was performed using a nonlinear mixed effects modeling method.

Results

Vinorelbine concentration-time profiles were best described by a three-compartment open model. Plasma clearance (CL) was high and positively related to lean body weight (LBW) and body surface area (BSA) or to a combination of height and body weight (BW). Elevated serum alkaline phosphatases had a negative effect on CL. Typical population estimates of CL and central distribution volume (V1) were 74.2 l/h and 7.8 l, respectively. The interindividual population coefficients of variation for CL and V1 were 17.0% and 32.0%, respectively. The stability and predictive performance of the final population pharmacokinetic model were assessed using 200 bootstrap samples of the original data.

Conclusion

This study identified combined effects of BSA and serum alkaline phosphatases on clearance. These results partly support the conventional dose adjustment of vinorelbine based on BSA, but suggest dose modification in cases of extreme values of serum alkaline phosphatases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ALT:

Alanine amino transferase

AST:

Aspartate amino transferase

AUC:

Area under the concentration curve

BSA:

Body surface area

BW:

Body weight

CL:

Clearance

ISV:

Intersubject variability

LBW:

Lean body weight

OFV:

Objective function value

SAP:

Serum alkaline phosphatases

SCr:

Serum creatinine

V1 :

Distribution volume

References

  1. Chatelut E, Boddy AV, Peng B, Rubie H, Lavit M, Dezeuze A, Pearson AD, Roche H, Robert A, Newell DR, Canal P (1996) Population pharmacokinetics of carboplatin in children. Clin Pharmacol Ther 59:436

    CAS  PubMed  Google Scholar 

  2. Freyer G, Tranchand B, Ligneau B, Ardiet C, Souquet PJ, Court-Fortune I, Riou R, Rebattu P, Boissel JP, Trillet-Lenoir V, Girard P (2000) Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study. Br J Clin Pharmacol 50:315

    CAS  PubMed  Google Scholar 

  3. Gallo JM, Laub PB, Rowinsky EK, Grochow LB, Baker SD (2000) Population pharmacokinetic model for topotecan derived from phase I clinical trials. J Clin Oncol 18:2459

    CAS  PubMed  Google Scholar 

  4. Gauvin A, Pinguet F, Culine S, Astre C, Gomeni R, Bressolle F (2000) Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer. Clin Cancer Res 6:2690

    CAS  PubMed  Google Scholar 

  5. Gauvin A, Pinguet F, Culine S, Astre C, Cupissol D, Bressolle F (2002) Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer. Cancer Chemother Pharmacol 49:48

    Article  PubMed  Google Scholar 

  6. Gauvin A, Pinguet F, Culine S, Astre C, Gomeni R, Bressolle F (2002) A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer. Anticancer Drugs 13:473

    Article  PubMed  Google Scholar 

  7. Gurney HP, Ackland S, Gebski V, Farrell G (1998) Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation. J Clin Oncol 16:2299

    CAS  PubMed  Google Scholar 

  8. Khayat D, Covelli A, Variol P (1995) Phase I and pharmacologic study of intravenous vinorelbine in patients with solid tumors. Proc Am Soc Clin Oncol 14:371

    Google Scholar 

  9. Marquet P, Lachatre G, Debord J, Eichler B, Bonnaud F, Nicot G (1992) Pharmacokinetics of vinorelbine in man. Eur J Clin Pharmacol 42:545

    Google Scholar 

  10. Mouly S, Aymard G, Tillement JP, Caulin C, Bergmann JF, Urien S (2001) Increased oral gancyclovir bioavailability in HIV-infected patients with chronic diarrhea and wasting syndrome—a population pharmacokinetic study. Br J Clin Pharmacol 51:557

    Article  PubMed  Google Scholar 

  11. Nguyen L, Tranchand B, Puozzo C, Variol P (2002) Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials. Br J Clin Pharmacol 53:459

    CAS  PubMed  Google Scholar 

  12. Parke J, Charles BG (2000) Factors affecting oral cyclosporin disposition after heart transplantation: bootstrap validation of a population pharmacokinetic model. Eur J Clin Pharmacol 56:481

    Article  PubMed  Google Scholar 

  13. Sabot C, Marquet P, Debord J, Carpentier N, Merle L, Lachatre G (1998) Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients. Eur J Clin Pharmacol 54:171

    Google Scholar 

  14. Schilling T, Fiebig HH, Kerpel-Fronius S, Winterhalter B, Variol P, Tresca P, Heinrich B, Hanauske AR (1996) Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients. Invest New Drugs 14:371

    CAS  PubMed  Google Scholar 

  15. Urien S (1997) MP2 (V 2.0)—a Windows application for population pharmacokinetics. In: Aarons L, Balant LP, Danhof M, et al (eds) The population approach: measuring and managing variability in response, concentration. European Community, Brussels, p 419

  16. Urien S, Bree F, Breillout F, Bastian G, Krikorian A, Tillement JP (1993) Vinorelbine high-affinity binding to human platelets and lymphocytes: distribution in human blood. Cancer Chemother Pharmacol 32:231

    CAS  PubMed  Google Scholar 

  17. Urien S, Fumoleau P, Campone M, Kerbrat P, Bonneterre J, Fargeot P, Deporte-Fety R (2003) Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer. Cancer Chemother Pharmacol 52:99

    PubMed  Google Scholar 

  18. Variol P, Nguyen L, Tranchand B, Puozzo C (2002) A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine. Eur J Clin Pharmacol 58:467

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre René Gauducheau, Nantes, France

    R. Deporte-Fety, P. Fumoleau & M. Campone

  2. Faculté de Médecine, Université de Marseille, France

    N. Simon

  3. Centre Eugène Marquis, Rennes, France

    P. Kerbrat

  4. Centre Oscar Lambret, Lille, France

    J. Bonneterre

  5. Centre Georges François Leclerc, Dijon, France

    P. Fargeot

  6. Centre René Huguenin, Saint Cloud, France

    S. Urien

  7. Centre René Gauducheau, Bd Jacques Monod, 44805, Saint Herblain Cedex, France

    R. Deporte-Fety

Authors
  1. R. Deporte-Fety
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Fumoleau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Campone
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Kerbrat
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Bonneterre
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Fargeot
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Urien
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Deporte-Fety.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deporte-Fety, R., Simon, N., Fumoleau, P. et al. Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer. Cancer Chemother Pharmacol 53, 233–238 (2004). https://doi.org/10.1007/s00280-003-0729-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-003-0729-2

Keywords

Search

Navigation